+

WO1997039107A3 - Methods for increasing the maturation of cells - Google Patents

Methods for increasing the maturation of cells Download PDF

Info

Publication number
WO1997039107A3
WO1997039107A3 PCT/CA1997/000231 CA9700231W WO9739107A3 WO 1997039107 A3 WO1997039107 A3 WO 1997039107A3 CA 9700231 W CA9700231 W CA 9700231W WO 9739107 A3 WO9739107 A3 WO 9739107A3
Authority
WO
WIPO (PCT)
Prior art keywords
increasing
maturation
cells
methods
provides
Prior art date
Application number
PCT/CA1997/000231
Other languages
French (fr)
Other versions
WO1997039107A2 (en
Inventor
Gregory Korbutt
Ray Rajotte
Original Assignee
Univ Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alberta filed Critical Univ Alberta
Priority to EP97915222A priority Critical patent/EP0894127A2/en
Priority to AU22834/97A priority patent/AU2283497A/en
Publication of WO1997039107A2 publication Critical patent/WO1997039107A2/en
Publication of WO1997039107A3 publication Critical patent/WO1997039107A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/24—Genital tract cells, non-germinal cells from gonads
    • C12N2502/246—Cells of the male genital tract, non-germinal testis cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention provides a method of increasing the maturation rate or proliferation rate of a cell utilizing microencapsulation techniques. The invention also provides a method of treatment of a subject having diabetes utilizing cells produced by the culture method described herein.
PCT/CA1997/000231 1996-04-12 1997-04-11 Methods for increasing the maturation of cells WO1997039107A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP97915222A EP0894127A2 (en) 1996-04-12 1997-04-11 Methods for increasing the maturation of cells
AU22834/97A AU2283497A (en) 1996-04-12 1997-04-11 Methods for increasing the maturation of cells

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1531096P 1996-04-12 1996-04-12
US60/015,310 1996-04-12
US1973796P 1996-06-14 1996-06-14
US60/019,737 1996-06-14

Publications (2)

Publication Number Publication Date
WO1997039107A2 WO1997039107A2 (en) 1997-10-23
WO1997039107A3 true WO1997039107A3 (en) 1997-12-11

Family

ID=26687221

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA1997/000231 WO1997039107A2 (en) 1996-04-12 1997-04-11 Methods for increasing the maturation of cells

Country Status (4)

Country Link
EP (1) EP0894127A2 (en)
AU (1) AU2283497A (en)
CA (1) CA2179341A1 (en)
WO (1) WO1997039107A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352707B1 (en) 1992-02-24 2002-03-05 Anton-Lewis Usala Transplant encapsulation in a hydrogel matrix to obscure immune recognition
US6231881B1 (en) 1992-02-24 2001-05-15 Anton-Lewis Usala Medium and matrix for long-term proliferation of cells
AU2001265151A1 (en) 2000-05-31 2001-12-11 Encelle, Inc. Method of stimulating hair growth
AU2002211122B2 (en) * 2000-10-17 2005-06-23 Diatranz Otsuka Limited Preparation and xenotransplantation or porcine islets
US20050042746A1 (en) * 2001-09-28 2005-02-24 Olga Garkavenko Growing xenotransplant material in culture
KR20140077938A (en) * 2011-09-28 2014-06-24 아일렛 사이언시즈, 인코퍼레이티드 Ex Vivo Maturation Of Islet Cells
KR101914837B1 (en) * 2016-12-08 2018-11-02 서울대학교산학협력단 Method for Isolating Pancreatic Islet of Neonatal Piglets
CN115197890A (en) * 2022-06-02 2022-10-18 成都中科奥格生物科技有限公司 A kind of islet cell culture medium and preparation method and use thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127989A2 (en) * 1983-06-01 1984-12-12 Connaught Laboratories Limited Microencapsulation of living tissue and cells
US4673566A (en) * 1983-06-01 1987-06-16 Connaught Laboratories Limited Microencapsulation of living tissue and cells
EP0363125A2 (en) * 1988-10-03 1990-04-11 Hana Biologics Inc. Proliferated pancreatic endocrine cell product and process
US5227298A (en) * 1990-08-17 1993-07-13 The Trustees Of Columbia University In The City Of New York Method for microencapuslation of cells or tissue
WO1994026915A1 (en) * 1993-05-10 1994-11-24 The Regents Of The University Of Michigan Gene transfer into pancreatic and biliary epithelial cells
WO1995019743A1 (en) * 1994-01-24 1995-07-27 The Regents Of The University Of California Multiple layer alginate coatings of biological tissue for transplantation
WO1996040178A1 (en) * 1995-06-07 1996-12-19 Research Corporation Technologies, Inc. Use of co-localized islets and sertoli cells in xenograft cellular transplants
WO1997016536A1 (en) * 1995-10-30 1997-05-09 Vivorx, Inc. Method for ex vivo proliferation and differentiation of adult pancreatic islet cells, media useful therefor and uses thereof

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0127989A2 (en) * 1983-06-01 1984-12-12 Connaught Laboratories Limited Microencapsulation of living tissue and cells
US4673566A (en) * 1983-06-01 1987-06-16 Connaught Laboratories Limited Microencapsulation of living tissue and cells
EP0363125A2 (en) * 1988-10-03 1990-04-11 Hana Biologics Inc. Proliferated pancreatic endocrine cell product and process
US5227298A (en) * 1990-08-17 1993-07-13 The Trustees Of Columbia University In The City Of New York Method for microencapuslation of cells or tissue
WO1994026915A1 (en) * 1993-05-10 1994-11-24 The Regents Of The University Of Michigan Gene transfer into pancreatic and biliary epithelial cells
WO1995019743A1 (en) * 1994-01-24 1995-07-27 The Regents Of The University Of California Multiple layer alginate coatings of biological tissue for transplantation
WO1996040178A1 (en) * 1995-06-07 1996-12-19 Research Corporation Technologies, Inc. Use of co-localized islets and sertoli cells in xenograft cellular transplants
WO1997016536A1 (en) * 1995-10-30 1997-05-09 Vivorx, Inc. Method for ex vivo proliferation and differentiation of adult pancreatic islet cells, media useful therefor and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KORBUTT G.S. ET AL.: "Large scale isolation, growth and function of porcine neonatal islet cells", JOURNAL OF CLINICAL INVESTIGATION, vol. 97, no. 9, 1 May 1996 (1996-05-01), NEW YORK, US, pages 2119 - 2129, XP002040062 *
SELAWRY H.P. ET AL.: "Sertoli cell-induced effects on functional and structural characteristics of isolated neonatal porcine islets", CELL TRANSPLANTATION, vol. 5, no. 5, 1996, NEW YORK, pages 517 - 524, XP002040065 *

Also Published As

Publication number Publication date
AU2283497A (en) 1997-11-07
CA2179341A1 (en) 1997-10-13
WO1997039107A2 (en) 1997-10-23
EP0894127A2 (en) 1999-02-03

Similar Documents

Publication Publication Date Title
ZA979229B (en) Process for producing L-amino acid through fermentation.
AU6479596A (en) Methods for treating diabetes
EP1382399B8 (en) Method for repelling or eliminating harmful organism
EP0737442A4 (en) Plaster for testing and method of testing
AU7662896A (en) Method for the production of hybrid plants
EP1243608A3 (en) Process for producing poly(alkylene oxide) and product thereof
AU8993598A (en) Method for improving soil microorganism population
AU3890795A (en) Improved method for nucleotide sequence amplification
GR3027621T3 (en) Mammalian cell cycle protein
AU7760094A (en) Process for lysing mycobacteria
ZA985026B (en) Method for enhancing the activity of an enzyme.
WO1997039107A3 (en) Methods for increasing the maturation of cells
AU1846297A (en) Method for inhibiting tumor cell growth
AU6372099A (en) Method for the generation of dna fingerprints
EP1334981A3 (en) Method for purifying keratinocyte growth factors
AU5106696A (en) Novel, defined enzyme mixtures for obtaining cells and for wound treatment
AU2493695A (en) Process for lysing mycobacteria
WO1998028299A3 (en) Imidazopyridazines
ZA978494B (en) Method for inhibiting the growth of mammalian cells.
AU1711692A (en) Method for regulating enzyme activities by noble gases
AU744075C (en) Method for producing arbor crops by photoautotrophic culture
AU6820096A (en) Selective process for the deacylation of acylated compounds
ZA988025B (en) Method for enhancing the activity of an enzyme.
AU5143096A (en) Method for identifying biologically active substances by the ir effect on living cells
AU4070897A (en) Method for treating diabetes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN YU AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN YU AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1997915222

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1997915222

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97536602

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1997915222

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载